535 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Activest Wealth Management

Activest Wealth Management acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 535 shares of the company’s stock, valued at approximately $50,000.

A number of other large investors also recently bought and sold shares of the business. Pathway Financial Advisers LLC purchased a new position in GE HealthCare Technologies in the first quarter worth $25,000. LGT Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Fred Alger Management LLC purchased a new stake in GE HealthCare Technologies in the second quarter valued at approximately $26,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Finally, Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies during the 3rd quarter valued at approximately $26,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded down $0.37 during trading hours on Thursday, reaching $84.53. 742,833 shares of the company’s stock were exchanged, compared to its average volume of 3,048,487. GE HealthCare Technologies Inc. has a 1-year low of $66.39 and a 1-year high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $38.62 billion, a price-to-earnings ratio of 23.32, a P/E/G ratio of 2.96 and a beta of 1.24. The company has a 50-day moving average of $88.54 and a 200 day moving average of $83.58.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same period last year, the firm posted $0.99 EPS. GE HealthCare Technologies’s quarterly revenue was up .9% on a year-over-year basis. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have commented on GEHC shares. Stifel Nicolaus upped their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Wednesday, September 18th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Finally, UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.